3.4.23.22	-	30616, 30629, 653831, 754383, 754385	
3.4.23.22	complexed with H261, crystals grow in two different crystal forms with the same monoclinic sopace group, P2(1), unit cell parameters a : 43.0A, b : 75.7A, c : 42.9A	649119	
3.4.23.22	complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin	30636	
3.4.23.22	crystal structure of enzyme bound to inhibitor Pd130328, inhibitor binding structure and analysis	670005	
3.4.23.22	in complex with gem-diol inhibitor PD-135,040, hanging-drop vapour-diffusion method, space group P2(1), unit-cell parameters a : 53.20, b : 73.25, c : 46.00	649236	
3.4.23.22	of inhibition of endothiapepsin by cyclohexyl renin inhibitors	30635	
3.4.23.22	of the complex between endothiapepsin and an oligopeptide inhibitor	30638	
3.4.23.22	sitting drop vapor diffusion method, using 0.1 M NH4Ac, 0.1 M acetate buffer, pH 4.6, and 26% (w/v) PEG 4000	717977	
3.4.23.22	space group P2(1), in complex with H189 unit cell parameters a : 42.48, b : 75.78, c : 42.99, in complex with CP-80,794 unit cell parameters a : 42.55, b : 74.62, c : 44.43, in complex with CP-129,541 unit cell parameters a : 42.47, b : 74.31, c : 42.81, in complex with PD-130,328 unit cell parameters a : 43.88, b : 75.44, c : 43.23, in complex with H256 unit cell parameters a : 43.88, b : 75.44, c : 43.23	652883	
3.4.23.22	structure studied by neutron crystallography, crystals are monocliic, P2(1), unit cell dimensions a : 43.1 A, b : 75.7 A, c : 42.9 A, endothiapepsin-H261 complex	650030	
3.4.23.22	three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin	30637	
3.4.23.22	using ammonium sulfate as precipitant at pH 4.6, X-ray diffraction structure determination and analysis at 2.1 A resolution, multiple isomorphous replacement	668786	
3.4.23.22	X-ray crystallographic analysis	30635, 30636